Thought I'd post something here but only because of my interest in cancer treatments.

Like Telix and Clarity, Radiopharm is also working on targeted cancer treatments and diagnostics. But in interest of time I won't go through the details as that is not my intention.

Unfortunately Radiopham flopped on IPO and has underperformed ever since as detailed by the AFR:

https://www.afr.com/companies/healthcare-and-fitness/radiopharm-theranostics-tanks-on-asx-debut-20211125-p59c7k

Some of the investors that got burnt:

The early stage company does not have revenue from licence arrangements or product sales. It is developing a platform of radiopharmaceutical products for diagnostic and therapeutic cancer treatment.

Shanghai-based NanoMab Technologies is the second-largest shareholder at 8.33 per cent. Other major shareholders include institutional backers Alex Waislitz’s Thorney Technologies and Frazis Capital Partners.

The chief executive of ASX-listed Imugene, Leslie Chong, and other Imugene supporters are also backing the company, including Emma & Tom’s co-founder Emma Welsh and cattleman Jack Mann (who owns more than 5 per cent of Imugene).

Others to buy into the float include CHAMP Ventures’ Su-Ming Wong, fashion designer and Celebrity MasterChef contestant Collette Dinnigan and Shark Tank’s Andrew Banks.

I'm not sure if Frazis and those celebrities are still investors.

The latest report had lots of contingent liabilities.

Anyway, I thought I'd point this out as thought this might be useful info before looking at Radiopharm.